EGFRvIII antibody

• Catalog Number: orb191506
• Category: Antibodies
• Description: EGFRvIII antibody
• Target: EGFRvIII
• Clonality: Polyclonal
• Species/Host: Rabbit
• Isotype: IgG2a
• Conjugation: Unconjugated
• Reactivity: Human, Mouse
• Form/Appearance: 10 mM PBS, 0.02% sodium azide
• Concentration: - 100 μg (in 200 μl): 0.5 mg/ml- 200 μg (in 400 μl): 0.5 mg/ml
• Purity: Polyclonal antibodies are purified by peptide affinity chromatography
• Immunogen: KLH conjugated synthetic peptide derived from human EGFRvIII. Please contact us for the exact immunogen sequence. The peptide is available as orb374827.
• UniProt ID: Q504U8, Q01279
• Tested applications: IHC-P, WB
• Dilution range: WB: 2 μg/ml, IHC-P: 1:200
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Alternative names: anti EGFR VIII antibody, anti EGFRviii antibody, a
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

WB analysis of human breast cancer tissue using EGFRvIII (dilution of primary antibody - 2 ug/ml)

Immunohistochemical staining of paraffin embedded human endometrial cancer tissue using anti-EGFRvIII (primary antibody at 1:200)

IHC-P staining of human endometrial cancer tissue using EGFRvIII antibody (dilution at 1:200)

Western blot analysis of human breast cancer 3 (lane 1), breast cancer 2 (lane 2), breast cancer 1 (lane 3) using EGFRvIII antibody (Dilution at 2 ug/ml)

Immunohistochemical staining of human mammary fibroma tissue using EGFRvIII antibody (dilution of primary antibody - 1:200)

IHC-P image of human mammary fibroma tissue using EGFRvIII antibody (dilution of primary antibody at 1:200)

IHC-P from different cancer patients(Adenocarcinoma).

IHC-P from different cancer patients(Adenocarcinoma).

IHC-P from different cancer patients(Adenocarcinoma).